Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Allison P. Jacob"'
Autor:
Stefania Oliva, Elisa Genuardi, Maria Teresa Petrucci, Mattia D'Agostino, Daniel Auclair, Antonio Spadano, Allison P. Jacob, Michele Cea, Luca De Rosa, Alessandro Gozzetti, Marina Ruggeri, Andrea Capra, Milena Gilestro, Norbert Pescosta, Angelo D. Palmas, Agostina Siniscalchi, Ilan R. Kirsch, Paolo Corradini, Pellegrino Musto, Mario Boccadoro, Elena Zamagni, Francesca Gay
Publikováno v:
Blood. 136:44-45
Background. In multiple myeloma (MM), the role of minimal residual disease (MRD) by multiparameter flow cytometry (MFC) and next-generation sequencing (NGS) is well established (H. Avet-Loiseau et al. IMW 2019, S. Oliva et al. EHA 2020). Aims. The ai
Autor:
Sarah A. Holstein, Stefania Oliva, Theresa Hahn, Parameswaran Hari, Qian Shi, Nikhil C. Munshi, Philip L. McCarthy, Zaid S. Al-Kadhimi, Edward A. Stadtmauer, Stephanie Waldvogel, Luciano J. Costa, Marcelo C. Pasquini, Allison P. Jacob, Jens Hillengass
Publikováno v:
Biol Blood Marrow Transplant
The third annual Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling was held on November 29, 2018, at the American Society of Hematology (ASH) annual meeting. Thi
Autor:
Allison P. Jacob, Vaishali Sanchorawala, Cindy Varga, Mariateresa Fulcinti, Nikhil C. Munshi, Shayna Sarosiek
Publikováno v:
Blood. 134:4353-4353
Background: AL amyloidosis is a bone marrow disorder in which clonal plasma cells produce light chains that misfold and deposit in vital organs, such as the kidneys and heart, leading to organ failure and eventual death. Treatment is directed towards
Autor:
Stefania Oliva, Elisa Genuardi, Angelo Belotti, Pio Manlio Mirko Frascione, Monica Galli, Andrea Capra, Massimo Offidani, Federico Vozella, Renato Zambello, Daniel Auclair, Agostina Siniscalchi, Jennifer Yesil, Ombretta Annibali, Ilan M. Kirsch, Simona Caltagirone, Allison P. Jacob, Stelvio Ballanti, Angelo D. Palmas, Antonio Ledda, Paolo Corradini, Paola Omedé, Michele Cavo, Pellegrino Musto, Mario Boccadoro, Francesca Gay
Publikováno v:
Blood. 134:4322-4322
Background: The role of Minimal residual disease (MRD) as surrogate for survival in Multiple Myeloma (MM) patients is well established. Therefore, new response criteria recommend including Multiparameter Flow cytometry (MFC) and next generation Seque
Autor:
Neha Korde, Hani Hassoun, Gunjan L. Shah, Malin Hultcrantz, David J. Chung, Theresia Akhlaghi, Even H Rustad, Sham Mailankody, Ola Landgren, Sergio Giralt, Venkata Yellapantula, Allison P. Jacob, Oscar B Lahoud, Akshar Patel, Eric L. Smith, Heather Landau, Nikoletta Lendvai, Alexander M. Lesokhin, Elli Papaemmanuil, Michael Scordo
Publikováno v:
Blood. 132:3184-3184
Background Minimal residual disease (MRD) negativity is a strong predictor for outcome in multiple myeloma. Next generation sequencing (NGS) for immunoglobulin heavy chain and kappa light chain VDJ rearrangements has become increasingly more common f